BD FACSLyric Flow Cytometer (3-1, 4-2, 4-2-2 and 4-3-3 optical configurations), BD FACSuite Clinical Software, BD Multitest 6-Color Assays, BD Multitest 4-Color Assays, BD Multitest 6-Color TBNK— 510(k) K170974

Substantially Equivalent

Becton, Dickinson and Company

FDA 510(k) clearance K170974 for BD FACSLyric Flow Cytometer (3-1, 4-2, 4-2-2 and 4-3-3 optical configurations), BD FACSuite Clinical Software, BD Multitest 6-Color Assays, BD Multitest 4-Color Assays, BD Multitest 6-Color TBNK, Substantially Equivalent on 2017-07-03. Applicant: Becton, Dickinson and Company. Device class: 2.

Clearance details

Applicant
Becton, Dickinson and Company
Product code
Code OYE
Device class
Class 2
Regulation
21 CFR 864.5220
Advisory panel
Hematology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
San Jose, CA, US
Download summary PDFView on FDA.gov ↗

Recent devices under product code OYE

view all

More clearances from Becton, Dickinson and Company

view all

Adverse events under product code OYE

product code OYE
Malfunction
828
Total
828

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Recalls naming K170974

K-number listed on FDA's recall record

Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K170974.

Data sourced from openFDA. This site is unofficial and independent of the FDA.